Clinical characteristics affecting weight loss in an East Asian population receiving semaglutide: A STEP 6 subgroup analysis

Authors:

Abstract
No abstract available
Funding Information
  • Novo Nordisk (GPP 2022)
  • Novo Nordisk Pharma Co Ltd

This publication has 23 references indexed in Scilit: